Contemporary Mortality Differences Between Primary Percutaneous Coronary Intervention and Thrombolysis in ST-Segment Elevation Myocardial Infarction

被引:0
|
作者
Claeys, Marc J. [1 ]
de Meester, Antoine [2 ]
Convens, Carl [3 ]
Dubois, Philippe [4 ]
Boland, Jean [5 ]
De Raedt, Herbert [6 ]
Vranckx, Pascal [7 ]
Coussement, Patrick [8 ]
Gevaert, Sofie [9 ]
Sinnaeve, Peter [10 ]
Evrard, Patrick [11 ]
Beauloye, Christophe [12 ]
Renard, Marc [13 ]
Vrints, Christiaan [1 ]
机构
[1] Univ Antwerp Hosp, Dept Cardiol, B-2650 Edegem, Belgium
[2] Hop Jolimont, Dept Cardiol, Haine St Paul, Belgium
[3] Ziekenhuis Netwerk Antwerpen, Dept Cardiol, Antwerp, Belgium
[4] Ctr Hosp Univ Charleroi, Dept Cardiol, Charleroi, Belgium
[5] Ctr Hosp Reg Citadelle Liege, Dept Cardiol, Liege, Belgium
[6] Onze Lieve Vrouwziekenhuis Ziekenhuis Aalst, Dept Cardiol, Aalst, Belgium
[7] Virga Jesse Ziekenhuis, Dept Cardiol, Hasselt, Belgium
[8] AZ Sint Jan Brugge, Dept Cardiol, Brugge, Belgium
[9] Univ Ziekenhuis Gent, Dept Cardiol, Ghent, Belgium
[10] Univ Ziekenhuis Leuven, Dept Cardiol, Leuven, Belgium
[11] UCL Mt Godinne, Dept Cardiol, Yvoir, Belgium
[12] UCL Louvain, Dept Cardiol, Louvain, Belgium
[13] Univ Libre Bruxelles, Brussels, Belgium
关键词
TIMI RISK SCORE; PRIMARY ANGIOPLASTY; IMMEDIATE ANGIOPLASTY; REPERFUSION THERAPY; HOSPITAL MORTALITY; NATIONAL REGISTRY; LONG; MANAGEMENT; TRIAL; FIBRINOLYSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Current ST-segment elevation myocardial infarction guidelines regarding reperfusion strategy are based on trials conducted before the application of routine invasive evaluation after thrombolysis. Modern thrombolysis may affect the previously observed mortality difference between primary percutaneous coronary intervention (PPCI) and thrombolysis. Methods: In-hospital mortality was prospectively assessed in 5295 patients with ST-segment elevation myocardial infarction admitted to 73 Belgian hospitals from July 1, 2007, through December 31, 2009. A total of 4574 patients (86.4%) were treated with PPCI and 721 (13.6%) received thrombolysis; of these thrombolysis patients, 603 (83.6%) underwent subsequent invasive evaluation. The Thrombolysis in Myocardial Infarction risk score was used to stratify the study population by low (n = 1934), intermediate (n = 2382), and high (n = 979) risk. Results: In-hospital mortality in the PPCI patients was 5.9% vs 6.6% in the thrombolysis patients. After adjustment for differences in baseline risk profile, a significant mortality benefit was only present in the high-risk groups: 23.7% in the PPCI patients vs 30.6% in the thrombolysis patients. For patients not at high risk, the mortality difference was marginal. For low-risk patients, mortality was 0.3% in the PPCI patients vs 0.4% in the thrombolysis patients. For intermediate-risk patients, mortality was 2.9% in the PPCI patients vs 3.1% in the thrombolysis patients. Subgroup analysis revealed that the mortality benefit of PPCI compared with early thrombolysis (door-to-needle time <30 minutes) was offset if the door-to-balloon time exceeded 60 minutes. Conclusions: Modern thrombolytic strategies have substantially attenuated the absolute mortality benefit of PPCI over thrombolysis, particularly in patients not at high risk. Our study findings suggest that target door-to-balloon time should be less than 60 minutes to maintain the lowest mortality rates.
引用
收藏
页码:544 / 549
页数:6
相关论文
共 50 条
  • [21] Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era
    Kahn, Matthew B.
    Cubbon, Richard M.
    Mercer, Ben
    Wheatcroft, Alison C. G.
    Gherardi, Guy
    Aziz, Amir
    Baliga, Vivek
    Blaxill, Jonathan M.
    McLenachan, Jim M.
    Blackman, Daniel J.
    Greenwood, John P.
    Wheatcroft, Stephen B.
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (01) : 3 - 9
  • [22] Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Rakowski, Tomasz
    Siudak, Zbigniew
    Dziewierz, Artur
    Dubiel, Jacek S.
    Dudek, Dariusz
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (03) : 397 - 403
  • [23] Experience of primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction at a referral healthcare centre in India
    Rajasekhar, D.
    Vanajakshamma, V.
    Vamsidhar, A.
    Babu, Boochi M.
    Latheef, K.
    NATIONAL MEDICAL JOURNAL OF INDIA, 2015, 28 (06) : 276 - 279
  • [24] Temporal trends and in-hospital outcomes of primary percutaneous coronary intervention in nonagenarians with ST-segment elevation myocardial infarction
    Kim, Joon Young
    Jeong, Myung Ho
    Choi, Yong Woo
    Ahn, Yong Keun
    Chae, Shung Chull
    Hur, Seung Ho
    Hong, Taek Jong
    Kim, Young Jo
    Seong, In Whan
    Chae, In Ho
    Cho, Myeong Chan
    Yoon, Jung Han
    Seung, Ki Bae
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (06) : 821 - 828
  • [25] On- Versus Off-Hours Presentation and Mortality of ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention
    Lattuca, Benoit
    Kerneis, Mathieu
    Saib, Anis
    Nguyen, Lee S.
    Payot, Laurent
    Barthelemy, Olivier
    Le Feuvre, Claude
    Helft, Gerard
    Choussat, Remi
    Collet, Jean-Philippe
    Montalescot, Gilles
    Silvain, Johanne
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (22) : 2260 - 2268
  • [26] Clinical Characteristics and Outcomes in Young Patients With ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention
    Gao, Ming
    Zhao, Waiou
    Zhang, Zhiguo
    Zhang, Weihua
    Zheng, Yang
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2018, 355 (06) : 544 - 552
  • [27] Association of coronary artery dominance and mortality rate and complications in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Mikaeilvand, Amir
    Firuozi, Ata
    Basiri, Hosseinali
    Varghaei, Aida
    Izadpanah, Peyman
    Kojuri, Javad
    Abdi-Ardekani, Alireza
    Attar, Armin
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2020, 25
  • [28] A Risk Score for No Reflow in Patients With ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention
    Wang, Jin-Wen
    Zhou, Zi-Qiang
    Chen, Yun-Dai
    Wang, Chang-Hua
    Zhu, Xiao-ling
    CLINICAL CARDIOLOGY, 2015, 38 (04) : 208 - 215
  • [29] Results of the Croatian Primary Percutaneous Coronary Intervention Network for Patients With ST-Segment Elevation Acute Myocardial Infarction
    Heitzler, Vjeran Nikolic
    Babic, Zdravko
    Milicic, Davor
    Bergovec, Mijo
    Raguz, Miroslav
    Mirat, Jure
    Strozzi, Maja
    Plazonic, Zeljko
    Giunio, Lovel
    Steiner, Robert
    Starcevic, Boris
    Vukovic, Ivica
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (09) : 1261 - 1267
  • [30] Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Gupta, Tanush
    Kolte, Dhaval
    Khera, Sahil
    Harikrishnan, Prakash
    Mujib, Marjan
    Aronow, Wilbert S.
    Jain, Diwakar
    Ahmed, Ali
    Cooper, Howard A.
    Frishman, William H.
    Bhatt, Deepak L.
    Fonarow, Gregg C.
    Panza, Julio A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (04):